Successful exhibition at ISHA in the US

RNS Number : 4345O
Surgical Innovations Group PLC
11 October 2012

Surgical Innovations Group plc

("SI" or the "Company")


Successful exhibition at ISHA in the US


Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), announces a successful ISHA (International Society of Hip Arthroscopy) exhibition last week in Boston, MA where the Company's pre-production hip arthroscopy products were well-received by surgeons from across the globe.


The Company said it was encouraging to see how its portfolio of laparoscopic instrumentation can successfully transfer to the arthroscopy market giving surgeons improved access, safety and visualisation during surgical procedures.


The technology and IP used in SI's port access system and retraction devices created substantial interest from the international surgeons, with many keen to work with the Company to develop the prototypes further and offer clinical feedback over the coming months.


The consensus amongst surgeons was that new innovative instrumentation was needed in the hip arthroscopic market to respond to the growing development of the specialism, something which SI is ideally placed to provide. The feedback from the congress has also highlighted new product opportunities that will ultimately increase the effectiveness and safety of the procedure itself.


Graham Bowland, CEO of SI said: "It was promising to see the high number and international diversity of surgeons in attendance at ISHA.  It is clear there is a passion to drive forward the hip arthroscopy discipline as a key method of treatment for various forms of hip repair. We believe the technology transfer from our laparoscopic instrumentation into hip arthroscopy is well-placed to overcome the challenges hip arthroscopy specialists are facing, and with our in-house design and manufacture teams, SI can rapidly bring innovative products through from concept to ultimate clinical use.  SI is proud to be a part of this exciting new surgical discipline."


Leading UK hip arthroscopy surgeon, Sion Glyn Jones, said: "The market of hip arthroscopy has already demonstrated an exponential rise in the UK (450%), statistics that were presented at the British Osteopathic Association (BOA) earlier in the year.  Over the next few years this rise is expected to continue as improvements in technology are made, more surgeons adopt hip arthroscopy practices and patient demand increases. It is arguably the most rapidly growing field in orthopedic surgery."


Surgical Innovations Group plc

Graham Bowland, Chief Executive Officer

Tel: +44 (0) 113 230 7597



Seymour Pierce Limited

Mark Percy (Corporate Finance)

Tel: +44 (0) 20 7107 8000

David Banks (Corporate Broking)




Walbrook PR Ltd

Tel: +44 (0) 20 7933 8780

Paul McManus

Mob: 07980 541 893 or

Lianne Cawthorne

Mob: 07584 391 303 or



Notes to Editors:


About Surgical Innovations Group plc


Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets. 


As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.


Over 120 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.


The Group's patented products are sold through three main channels:


SI brand

Through an established network of distribution partners, Surgical Innovations branded products are sold in major medical markets including North America, Britain, South East Asia, Australasia and the Indian subcontinent. 


OEM and IP

The Group supplies large medical device companies on an OEM basis, generating both sales and IP royalty fees.  Clients include Teleflex Medical, Olympus and CareFusion. 




SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime. 


For more information, see




This information is provided by RNS
The company news service from the London Stock Exchange
UK 100

Latest directors dealings